Ieva Bagdonaite, Samir Abdurahman, Mattia Mirandola, Denis Pasqual, Martin Frank, Yoshiki Narimatsu, Hiren J. Joshi, Sergey Y. Vakhrushev, Cristiano Salata, Ali Mirazimi, Hans H. Wandall: Targeting host O-linked glycan biosynthesis affects Ebola virus replication efficiency and reveals differential GalNAc-T acceptor site preferences on the Ebola virus glycoprotein. Journal of Virology, 17.5.2024, 98. vsk, nro 6, s. e00524–24. PubMed:38757972doi:10.1128/jvi.00524-24Artikkelin verkkoversio.
Ebola Virus Baylor College of Medicine, Texas: Molecular Virology and Microbiology. Viitattu 8.5.2013. (englanniksi)
biomedcentral.com
virologyj.biomedcentral.com
Johnson, Reed F. & Bell, Peter & Harty, Ronald N: Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphology. Virology Journal, 2006, nro 3, s. 31. BioMed Central Ltd.. doi:10.1186/1743-422X-3-31Artikkelin verkkoversio. Viitattu 13.10.2018 (englanniksi).
Wamala, Joseph F. & Lukwago, Luswa & Malimbo, Mugagga & Nguku, Patrick & Yoti, Zabulon & Musenero, Monica & Amone, Jackson & Mbabazi, William & Nanyunja, Miriam & Zaramba, Sam & Opio, Alex & Lutwama, Julius J. & Talisuna, Ambrose O. & Okware, Sam I.: Ebola Hemorrhagic Fever Associated with Novel Virus Strain, Uganda, 2007–2008. Emerging Infectious Disease, heinäkuu 2010, 16. vsk, nro 7. doi:10.3201/eid1607.091525Artikkelin verkkoversio. Viitattu 1.11.2014. (englanniksi)
Johnson, Reed F. & Bell, Peter & Harty, Ronald N: Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphology. Virology Journal, 2006, nro 3, s. 31. BioMed Central Ltd.. doi:10.1186/1743-422X-3-31Artikkelin verkkoversio. Viitattu 13.10.2018 (englanniksi).
Ieva Bagdonaite, Samir Abdurahman, Mattia Mirandola, Denis Pasqual, Martin Frank, Yoshiki Narimatsu, Hiren J. Joshi, Sergey Y. Vakhrushev, Cristiano Salata, Ali Mirazimi, Hans H. Wandall: Targeting host O-linked glycan biosynthesis affects Ebola virus replication efficiency and reveals differential GalNAc-T acceptor site preferences on the Ebola virus glycoprotein. Journal of Virology, 17.5.2024, 98. vsk, nro 6, s. e00524–24. PubMed:38757972doi:10.1128/jvi.00524-24Artikkelin verkkoversio.
Boubacar Diallo, Daouda Sissoko, Nicholas J. Loman, Hadja Aïssatou Bah, Hawa Bah, Mary Claire Worrell: Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 15.11.2016, nro 10, s. 1353–1356. PubMed:27585800doi:10.1093/cid/ciw601ISSN 1058-4838Artikkelin verkkoversio.
Ieva Bagdonaite, Samir Abdurahman, Mattia Mirandola, Denis Pasqual, Martin Frank, Yoshiki Narimatsu, Hiren J. Joshi, Sergey Y. Vakhrushev, Cristiano Salata, Ali Mirazimi, Hans H. Wandall: Targeting host O-linked glycan biosynthesis affects Ebola virus replication efficiency and reveals differential GalNAc-T acceptor site preferences on the Ebola virus glycoprotein. Journal of Virology, 17.5.2024, 98. vsk, nro 6, s. e00524–24. PubMed:38757972doi:10.1128/jvi.00524-24Artikkelin verkkoversio.
Boubacar Diallo, Daouda Sissoko, Nicholas J. Loman, Hadja Aïssatou Bah, Hawa Bah, Mary Claire Worrell: Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 15.11.2016, nro 10, s. 1353–1356. PubMed:27585800doi:10.1093/cid/ciw601ISSN 1058-4838Artikkelin verkkoversio.
Boubacar Diallo, Daouda Sissoko, Nicholas J. Loman, Hadja Aïssatou Bah, Hawa Bah, Mary Claire Worrell: Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 15.11.2016, nro 10, s. 1353–1356. PubMed:27585800doi:10.1093/cid/ciw601ISSN 1058-4838Artikkelin verkkoversio.
Boubacar Diallo, Daouda Sissoko, Nicholas J. Loman, Hadja Aïssatou Bah, Hawa Bah, Mary Claire Worrell: Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 15.11.2016, nro 10, s. 1353–1356. PubMed:27585800doi:10.1093/cid/ciw601ISSN 1058-4838Artikkelin verkkoversio.